MOACM
VNDA icon

Mutual of America Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Mutual of America Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,221
Closed -$73.9K – 1485
2023
Q2 		$73.9K Sell
11,221
-473
-4% -$3.03K ﹤0.01% 1462
2023
Q1 		$79.4K Sell
11,694
-166
-1% -$1.17K ﹤0.01% 1454
2022
Q4 		$87.6K Buy
11,860
+607
+5% +$5.91K ﹤0.01% 1440
2022
Q3 		$111K Buy
11,253
+1,765
+19% +$18.6K ﹤0.01% 1509
2022
Q2 		$103K Buy
9,488
+1,460
+18% +$15.1K ﹤0.01% 1494
2022
Q1 		$91K Buy
8,028
+416
+5% +$5.47K ﹤0.01% 1541
2021
Q4 		$119K Buy
7,612
+192
+3% +$3.35K ﹤0.01% 1490
2021
Q3 		$127K Sell
7,420
-479
-6% -$8.39K ﹤0.01% 1472
2021
Q2 		$170K Buy
7,899
+570
+8% +$10.2K ﹤0.01% 1423
2021
Q1 		$110K Buy
7,329
+469
+7% +$7.59K ﹤0.01% 1525
2020
Q4 		$90K Buy
6,860
+278
+4% +$3.35K ﹤0.01% 1507
2020
Q3 		$64K Buy
6,582
+3,941
+149% +$42.1K ﹤0.01% 1503
2020
Q2 		$30K Buy
2,641
+325
+14% +$3.68K ﹤0.01% 1467
2020
Q1 		$24K Buy
2,316
+423
+22% +$5.25K ﹤0.01% 1456
2019
Q4 		$31K Sell
1,893
-72
-4% -$1.09K ﹤0.01% 1472
2019
Q3 		$26K Buy
1,965
+67
+4% +$934 ﹤0.01% 1514
2019
Q2 		$27K Buy
1,898
+383
+25% +$6.09K ﹤0.01% 1499
2019
Q1 		$28K Buy
1,515
+213
+16% +$4.85K ﹤0.01% 1445
2018
Q4 		$34K Buy
+1,302
New +$30.6K ﹤0.01% 1334

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mutual of America Capital Management's VNDA Position: Q3 2023 in Review

Mutual of America Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 11,221 shares — an estimated $73.9K sold.

Mutual of America Capital Management first reported a position in VNDA in Q4 2018 and held it in 19 quarters. The position peaked at $170K in Q2 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Mutual of America Capital Management reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 11,221 Vanda Pharmaceuticals shares in Q3 2023, an estimated $73.9K.
  • Mutual of America Capital Management first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 19 quarters.
  • Mutual of America Capital Management's Vanda Pharmaceuticals position peaked at $170K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Mutual of America Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.